Dr. Alex Matter CML Chronic Myeloid Leukemia
''Dr. Alex Matter is best known for his contribution to the development of
Glivec/Gleevec, one of the world’s first tyrosine kinase inhibitor drugs against
chronic myeloid leukemia (CML). Starting in the mid-eighties, Dr. Matter led a
team of close to 200 scientists at Novartis to discover and optimize the lead
compound and brought it all the way through its first clinical trial in 1998. In
a short span of 3 years, Glivec/Gleevec was given a very rare, fast track FDA
approval in 2001.''
Extract of CV of Alex Matter
ARTICLES
2013 Prize: Alex Matter, M.D.
April 6, 2013, National Foundation for Cancer Research
Dr. Alex Matter has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
January 29, 2013, National Foundation for Cancer research
Executive Summary of a Book: Magic Cancer Bullet
May 23, 2009, Discovery Medecine
2013 Prize: Alex Matter, M.D.
April 6, 2013, National Foundation for Cancer Research
Dr. Alex Matter has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
January 29, 2013, National Foundation for Cancer research
Executive Summary of a Book: Magic Cancer Bullet
May 23, 2009, Discovery Medecine
Modes of access to the website
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website.
(No registration required - Anonymous access)
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website.
(No registration required - Anonymous access)
2 - Reserved access to CMLeukemia private group
On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).
On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).